Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

[ad_1]

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *